Search by Drug Name or NDC
NDC 51224-0124-50 Methazolamide 50 mg/1 Details
Methazolamide 50 mg/1
Methazolamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TAGI Pharma, Inc.. The primary component is METHAZOLAMIDE.
MedlinePlus Drug Summary
Methazolamide is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision). Methazolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
Related Packages: 51224-0124-50Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Methazolamide
Product Information
| NDC | 51224-0124 |
|---|---|
| Product ID | 51224-124_666abc7f-c475-45cc-b288-28a3f7da887d |
| Associated GPIs | |
| GCN Sequence Number | 008169 |
| GCN Sequence Number Description | methazolamide TABLET 50 MG ORAL |
| HIC3 | R1E |
| HIC3 Description | CARBONIC ANHYDRASE INHIBITORS |
| GCN | 34740 |
| HICL Sequence Number | 003643 |
| HICL Sequence Number Description | METHAZOLAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Methazolamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methazolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHAZOLAMIDE |
| Labeler Name | TAGI Pharma, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215615 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51224-0124-50 (51224012450)
| NDC Package Code | 51224-124-50 |
|---|---|
| Billing NDC | 51224012450 |
| Package | 100 TABLET in 1 BOTTLE (51224-124-50) |
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.51831 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | METHAZOLAMIDE 50 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis